ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,571 | -35.2% | 13,385 | -9.0% | 0.04% | -33.9% |
| Q2 2023 | $95,052 | +26.3% | 14,714 | +47.4% | 0.06% | +36.6% |
| Q1 2023 | $75,272 | -46.3% | 9,983 | -27.8% | 0.04% | -43.8% |
| Q4 2022 | $140,068 | +19.7% | 13,827 | +16.4% | 0.07% | +55.3% |
| Q3 2022 | $117,000 | -6.4% | 11,876 | +0.8% | 0.05% | +2.2% |
| Q2 2022 | $125,000 | +8.7% | 11,784 | 0.0% | 0.05% | -9.8% |
| Q1 2022 | $115,000 | -35.4% | 11,784 | -5.6% | 0.05% | -23.9% |
| Q4 2021 | $178,000 | +2.3% | 12,482 | +44.1% | 0.07% | -13.0% |
| Q3 2021 | $174,000 | -13.0% | 8,664 | -4.9% | 0.08% | -6.1% |
| Q2 2021 | $200,000 | – | 9,111 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |